FDA Clearance Tracker · P120023-S004
KAMRA INLAY
Last checked: Nov 20, 2026Latest source record: May 16, 2017 (this decision)Source: openFDAMethods & limitations
Decided
May 16, 2017
Approved
Time to decision
230 days
Received Sep 28, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Corneagen
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EndoSerter-PL510(k)
K203586 · Decided Feb 2, 2022 · 421 days after receipt
Device type: Graft Insertion Instrument For Endothelial Keratoplasty (OTZ) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.